WST GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
West Pharmaceutical Services Inc
Exchange: NYSESector: HealthcareIndustry: Medical Instruments & Supplies
West Pharmaceutical Services, Inc. (West) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. Its business operations are organized into two segments: Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems). Its products include stoppers and seals for vials, prefillable syringe components and systems, components for intravenous and blood collection systems, safety and administration systems, advanced injection systems, and contract design and manufacturing services. Its customers include the global producers and distributors of pharmaceuticals, biologics, medical devices and personal care products.
Did you know?
Price sits at 63% of its 52-week range.
Current Price
$267.93
+3.07%GoodMoat Value
$166.89
37.7% overvaluedProfile
Valuation (TTM)
Market Cap$19.28B
P/E39.04
EV$16.90B
P/B6.07
Shares Out71.94M
P/Sales6.27
Revenue$3.07B
EV/EBITDA23.89
West Pharmaceutical Services Inc (WST) Quality Analysis
WST Profitability
Profitability trend analysis coming soon
WST Growth
Growth trend analysis coming soon
WST Financial Health
Financial health indicators coming soon
WST Quality & Fundamental Analysis
West Pharmaceutical Services Inc (WST) is a Healthcare company in the Medical Instruments & Supplies industry, listed on NYSE. This quality analysis page evaluates West Pharmaceutical Services Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
West Pharmaceutical Services Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 16.06% and a return on equity (ROE) of 15.54%. Return on assets (ROA) stands at 11.56%.
The debt-to-equity ratio is 0.10, with a current ratio of 3.02. Operating margin is 19.03%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether West Pharmaceutical Services Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.